Earnest Partners LLC Meridian Bioscience Inc Transaction History

Earnest Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$30.9 - $33.55 $110 Million - $120 Million	-3,564,922 Reduced 100.0%	141 $4,000
Q2 2022 Aug 12, 2022	SELL	$23.75 - $31.69 $2.18 Million - $2.91 Million	-91,880 Reduced 2.51%	3,565,063 $108 Million
Q1 2022 May 16, 2022	SELL	$19.97 - $26.94 $1.35 Million - $1.81 Million	-67,367 Reduced 1.81%	3,656,943 $94.9 Million
Q4 2021 Feb 07, 2022	SELL	$17.46 - $21.61 $3.13 Million - $3.87 Million	-179,250 Reduced 4.59%	3,724,310 $76 Million
Q3 2021 Nov 15, 2021	BUY	$17.35 - $22.5 $309,038 - $400,770	17,812 Added 0.46%	3,903,560 $75.1 Million
Q2 2021 Aug 16, 2021	SELL	$18.01 - $28.32 $8.21 Million - $12.9 Million	-456,086 Reduced 10.5%	3,885,748 $86.2 Million
Q1 2021 May 17, 2021	BUY	$19.76 - $29.89 $85.8 Million - $130 Million	4,341,834 New	4,341,834 $114 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Earnest Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Earnest Partners LLC with notifications on news.